Ali Behbahani

Affiliations

  • Large Shareholder at Bright Health Group Inc. (BHG), 2022-01-05
  • Large Shareholder at Metacrine Inc. (MTCR), 2021-12-27
  • Director at Black Diamond Therapeutics Inc. (BDTX), 2021-12-17
  • Director at Minerva Surgical Inc (UTRS), 2021-10-29
  • Large Shareholder at Trevi Therapeutics Inc. (TRVI), 2021-10-20
  • Large Shareholder, Director at Monte Rosa Therapeutics Inc. (GLUE), 2021-06-30
  • Director at Cvrx Inc. (CVRX), 2021-06-30
  • Director at Nkarta Inc. (NKTK), 2021-06-15
  • Director at Crispr Therapeutics Ag (CRSP), 2021-06-14
  • Director at Oyster Point Pharma Inc. (OYST), 2021-06-10
  • Large Shareholder at Marker Therapeutics Inc. (MRKR), 2021-03-18
  • Other at Regulus Therapeutics Inc. (RGLS), 2021-03-17
  • Large Shareholder at Savara Inc (SVRA), 2021-03-16
  • Large Shareholder, Director at Genocea Biosciences Inc. (GNCA), 2020-07-28
  • Large Shareholder at Akouos Inc. (AKUS), 2020-07-01
  • Director at Adaptimmune Therapeutics Plc (ADAP), 2020-07-01
  • Large Shareholder at Mirum Pharmaceuticals Inc. (MIRM), 2019-07-24
  • Large Shareholder at Arsanis Inc. (ASNS), 2018-07-17
  • Director at Nevro Corp (NVRO), 2018-05-24
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
TRVI $0.00 1,851,852 Large Shareholder 7,789,850 2021-10-18 Filing
GLUE $19.00 1,050,000 Large Shareholder, Director 7,692,298 2021-06-28 Filing
MRKR $1.75 5,714,285 Large Shareholder 10,714,285 2021-03-16 Filing
RGLS $0.62 4,398,602 Large Shareholder 6,451,056 2020-12-04 Filing
MTCR $13.00 769,230 Large Shareholder 3,060,527 2020-09-18 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MTCR $0.91 170,932 Large Shareholder 2,563,257 2021-12-22 Filing
MTCR $1.00 288,768 Large Shareholder 2,734,189 2021-12-22 Filing
MTCR $1.32 37,570 Large Shareholder 3,022,957 2021-12-10 Filing
TRVI $2.66 564 Large Shareholder 5,937,998 2020-04-03 Filing